Infos and Stock Alerts from FierceBiotech

				
FierceBiotech 
Web    : http://fiercebiotech.com/ | Company: FierceMarkets
Mail(1): editors@fiercebiotech.com | Mail(2): -
Adress : 1900 L Street NW, Suite 400, Washington, D.C. 20036


We saved 12 Stock Alerts from FierceBiotech

Date: Jun 02 2014 | Time: 09:25 EDT promoted ASCO
---Mailheader---> | 06.02.14 | ASCO Special: Merck, Bristol and Roche advance immuno-oncology drugs; GSK opens new cancer R&D chapter

Date: May 29 2014 | Time: 12:51 EDT promoted ASCO
---Mailheader---> | 05.29.14 | ASCO: Top R&D bets crest $1B in immuno-oncology; J&J bags new prostate cancer tech

Date: May 15 2014 | Time: 12:28 EDT promoted ASCO
---Mailheader---> | 05.15.14 | Bristol-Myers, AstraZeneca, Roche and Merck start scramble for ASCO spotlight; Another biotech IPO tests chilly market

Date: Jun 03 2013 | Time: 12:55 EDT promoted ASCO
---Mailheader---> | 06.03.13 | Sanofis PhIII failures trigger $285M charge; Clovis soars at ASCO

Date: Jun 03 2013 | Time: 09:19 EDT promoted ASCO
---Mailheader---> | 06.03.13 | ASCO SPECIAL EDITION: Immunotherapies in spotlight with breakthroughs and small victories

Date: May 31 2013 | Time: 12:48 EDT promoted ASCO
---Mailheader---> | 05.31.13 | ASCO fever starts with lung cancer in immunotherapy spotlight; Alzheimers startup shutters

Date: May 16 2013 | Time: 12:45 EDT promoted ASCO
---Mailheader---> | 05.16.13 | Bristol-Myers, Roche, Gilead grab ASCO spotlight with blockbuster hopefuls

Date: May 15 2013 | Time: 12:39 EDT promoted ASCO
---Mailheader---> | 05.15.13 | Bayer wins swift FDA nod for new prostate cancer med; Roches pre-ASCO exam

Date: May 13 2013 | Time: 12:35 EDT promoted ASCO
---Mailheader---> | 05.13.13 | Elan splurges with $1B deal on Theravance drugs; Marquee cancer drugs head to ASCO

Date: Jun 04 2012 | Time: 13:00 EDT promoted ASCO
---Mailheader---> | 06.04.12 | ASCO highlights: Key data from BMS, GSK, Roche and many others

Date: Jun 01 2012 | Time: 12:45 EDT promoted ASCO
---Mailheader---> | 06.01.12 | ASCO spotlight: Antibody-drug conjugates shine; Marina shutters RNAi ops

Date: May 30 2012 | Time: 12:52 EDT promoted ASCO
---Mailheader---> | 05.30.12 | Bristol-Myers grooms cancer drug for ASCO spotlight; Alnylam afflicted with fresh setback